中国医药(600056.SH)：注射用头孢呋辛钠获得药品补充申请批准通知书

格隆汇资讯08-08

格隆汇8月8日丨中国医药(600056.SH)公布，下属全资子公司海南通用三洋药业有限公司收到国家药品监督管理局核准签发的五份注射用头孢呋辛钠《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。注射用头孢呋辛钠最早是由英国葛兰素公司研制开发，为第二代头孢菌素类抗生素，具有广谱抗菌作用，适用范围广，可用于由特定微生物敏感菌株引起的感染：呼吸道感染、耳鼻喉感染、泌尿系感染、皮肤和软组织...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2457662533?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-08 16:48","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2457662533","market":"sh","top_or_hot":-1,"title":"中国医药(600056.SH)：注射用头孢呋辛钠获得药品补充申请批准通知书","media":"格隆汇资讯","content":"<div>\n<p>格隆汇8月8日丨中国医药(600056.SH)公布，下属全资子公司海南通用三洋药业有限公司收到国家药品监督管理局核准签发的五份注射用头孢呋辛钠《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。注射用头孢呋辛钠最早是由英国葛兰素公司研制开发，为第二代头孢菌素类抗生素，具有广谱抗菌作用，适用范围广，可用于由特定微生物敏感菌株引起的感染：呼吸道感染、耳鼻喉感染、泌尿系感染、皮肤和软组织...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080816484595884f32&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中国医药(600056.SH)：注射用头孢呋辛钠获得药品补充申请批准通知书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中国医药(600056.SH)：注射用头孢呋辛钠获得药品补充申请批准通知书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-08 16:48 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080816484595884f32&s=b><strong>格隆汇资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇8月8日丨中国医药(600056.SH)公布，下属全资子公司海南通用三洋药业有限公司收到国家药品监督管理局核准签发的五份注射用头孢呋辛钠《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。注射用头孢呋辛钠最早是由英国葛兰素公司研制开发，为第二代头孢菌素类抗生素，具有广谱抗菌作用，适用范围广，可用于由特定微生物敏感菌株引起的感染：呼吸道感染、耳鼻喉感染、泌尿系感染、皮肤和软组织...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080816484595884f32&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0175","symbol_name":"白马股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080816484595884f32&s=b","article_id":"2457662533","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080816484595884f32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2457662533","pubTimestamp":1723106918,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇8月8日丨中国医药(600056.SH)公布，下属全资子公司海南通用三洋药业有限公司收到国家药品监督管理局核准签发的五份注射用头孢呋辛钠《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。注射用头孢呋辛钠最早是由英国葛兰素公司研制开发，为第二代头孢菌素类抗生素，具有广谱抗菌作用，适用范围广，可用于由特定微生物敏感菌株引起的感染：呼吸道感染、耳鼻喉感染、泌尿系感染、皮肤和软组织感染、败血症、脑膜炎、淋病、骨和关节感染、产褥期和妇科感染等。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600056":"中国医药","BK0175":"白马股","BK0250":"批发","BK0010":"央企","BK0188":"融资融券","BK0028":"国家队","BK0082":"国资改革","BK0185":"二线龙头"},"translate_title":"China Pharmaceutical (600056. SH): Cefuroxime Sodium for Injection Obtained Approval Notice for Supplementary Drug Application","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600056":1},"content_text":"格隆汇8月8日丨中国医药(600056.SH)公布，下属全资子公司海南通用三洋药业有限公司收到国家药品监督管理局核准签发的五份注射用头孢呋辛钠《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。注射用头孢呋辛钠最早是由英国葛兰素公司研制开发，为第二代头孢菌素类抗生素，具有广谱抗菌作用，适用范围广，可用于由特定微生物敏感菌株引起的感染：呼吸道感染、耳鼻喉感染、泌尿系感染、皮肤和软组织感染、败血症、脑膜炎、淋病、骨和关节感染、产褥期和妇科感染等。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2457662533"}